University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Casgevy (exagamglogene autotemcel or exa-cel) became the first drug based on the CRISPR/Cas9 gene-editing technology ... which earned its discoverers a Nobel Prize in 2020. The one-shot therapy ...

In October, CRISPR Therapeutics co-founder Emmanuelle Charpentier and Intellia co-founder Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for their work on CRISP/Cas9. Join the ...

These pores allow the CRISPR-Cas9 platform to enter the cells and travel to the nucleus ... It will combine CRISPR technology developed at IGI – a joint UC Berkeley-UCSF initiative founded by Nobel ...

Within the human digestive tract are trillions of bacteria from thousands of different species. These bacteria form ...

Among the most exciting breakthroughs are gene therapy and gene editing, with CRISPR-Cas9 leading the charge ... Just six years later, after earning a Nobel Prize, CRISPR began to make its ...